Shariah compliance overview
HalalExelixis, Inc. (EXEL) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Exelixis, Inc.
Exelixis, Inc. operates as a biotechnology firm dedicated to combating cancer, primarily focusing on the identification, advancement, and marketing of novel oncological treatments within the United States.
Exelixis, Inc. (EXEL) operates in the Healthcare sector, in the Biotechnology industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 2.90% (limit 5%), interest-bearing debt is 0.00% (limit 30%) and interest-bearing securities and assets are 11.05% (limit 30%).
If you hold EXEL, give 2.90% of the dividends you receive to charity to purify the non-compliant share of its income.
- Business Activity
- 2.90%Limit 5%Pass
- Interest-bearing debt
- 0.00%Limit 30%Pass
- Interest-bearing securities and assets
- 11.05%Limit 30%Pass
- Dividend purification
- 2.90%Share of dividends to give to charityPurification calculator
Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Exelixis, Inc. (EXEL). Current Akinda screening label: Halal.
